JMP Securities reported that they have upgraded health care company, Allergan, Inc.(AGN) on Wednesday.
The firm has raised their rating on AGN from “Market Perform” to “Outperform,” and has given the company a $135 price target. This price target suggests a 20% increase from the stock’s current price of $108.12.
Analysts have upgraded the company due to a higher demand for Botox.
Allergan shares were up $1.42, or 1.33% during Wednesday morning trading. The stock has increased 25% in the past year.
The Bottom Line
Shares of Allergan, Inc.(AGN) have a 0.18% yield, based on Wednesday morning’s price of $108.12.
Allergan, Inc.(AGN) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars.